Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma

BACKGROUND: Abnormal autocrine fibroblast growth factor 19 (FGF19) production has been observed in several types of cancers, including hepatocellular carcinoma (HCC). In this study, we investigated the potential of serum FGF19 as a novel tumor marker of HCC based on a sandwich enzyme-linked immunoso...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Maeda, Takahiro, Kanzaki, Hiroaki, Chiba, Tetsuhiro, Ao, Junjie, Kanayama, Kengo, Maruta, Susumu, Kusakabe, Yuko, Saito, Tomoko, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Ogasawara, Sadahisa, Suzuki, Eiichiro, Ooka, Yoshihiko, Nakamoto, Shingo, Nakagawa, Ryo, Muroyama, Ryosuke, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Naoya
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6849282/
https://ncbi.nlm.nih.gov/pubmed/31718608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6322-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados